Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of D-2570 in Participants With Renal Impairment
NCT07715175Phase 1Recruiting
- Sponsor
- InventisBio
- Start
- Aug 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of D-2570 (4 arms), sponsored by InventisBio. Primary endpoints: Time to maximum measured plasma concentration at Day 9, Maximum observed plasma concentration at Day 9 and 7 more. Started Aug 2026; status: recruiting.
02
Drugs
D-2570
Beyond the preview
Go deeper on NCT07715175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07715175.